WHO strongly recommends antiviral drug for patients with non-severe covid-19: A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of hospital admission. WHO also makes a conditional recommendation for remdesivir in the same group of patients. Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended […]
WHO strongly recommends antiviral



